Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT03261739 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD

Interventions

BIOLOGICAL: RYI-018
BIOLOGICAL: Placebo

Sponsor

Bird Rock Bio, Inc.

Collaborators

[object Object]
[object Object]